New cancer drug WTX-330 shows promise in early human trial
NCT ID NCT05678998
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested a new drug called WTX-330 in 25 adults with advanced solid tumors or lymphoma that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink tumors. The study is now complete, and results will help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Winship Cancer Institute of Emory University
Atlanta, Georgia, 30322, United States
-
Facility Name: Roswell Park Comprehensive Cancer Care
Buffalo, New York, 14203, United States
-
HonorHealth
Scottsdale, Arizona, 85258, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Mass General Hospital
Boston, Massachusetts, 02114, United States
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Providence Cancer Institute Franz Clinic
Portland, Oregon, 97213, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States